CLINICAL_TRIALS
research
· 2025-09-03
Clinical Trial Update: Imaging With a PET Agent for Detection of Cancers of the Head and Neck [Phase 1, Phase 2]
Summary
A Phase 1/2 imaging trial using a PET agent to detect head and neck cancers is ongoing, sponsored by Memorial Sloan Kettering Cancer Center, currently active bu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING